All In Biotech

Drug Trial Radar · NCT00436033

A Multicentre Trial to Determine the Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia Syndrome

A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome

Last checked: Nov 20, 2026Latest source record: Jul 11, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,429 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,429

Actual

Start

Feb 2006

Primary completion

Sep 2007

Study completion Sep 2007

Sponsor

Lead sponsor
Pierre Fabre MedicamentIndustry
Sponsor type
Industry
First posted
Feb 16, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Investigation of efficacy and safety of treatment with milnacipran in the treatment of fibromyalgia syndrome.

Conditions

  • Fibromyalgia Syndrome

Interventions

  • milnacipranDrug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To demonstrate the efficacy of treatment with milnacipran as compared to placebo in the treatment of the fibromyalgia syndrome in outpatients after a 12-week period of fixed dose exposure through a primary composite criterionTime frame: 12 weeks

Locations

13 sites in 13 countries. Site status is shown where the registry gives one.

  • Rheumatology Ambulance

    Pardubice, Czechia

  • FREDERIKSBERG HOSPITAL - Clinic of Rheumatology

    Frederiksberg, Denmark

  • Kuopion Oma Laakari Oy

    Kuopio, Finland

  • Hopital Hotel Dieu

    Paris, France

  • KKSK KLINIKUM DER UNIVERSITAET ZU KOELN - Anaesthesiology and Intensive Care

    Cologne, Germany

  • Ospedale Luigi Sacco

    Milan, Italy

  • Center For Clinical Studies

    Lillehamer, Norway

  • "Nasz Lekarz"

    Torun, Poland

  • Hospital Egas Moniz

    Lisbon, Portugal

  • Dr I CANTACUZINO CLINICAL HOSPITAL

    Bucharest, Romania

  • Hospital de La Esperanza

    Barcelona, Spain

  • Gottfriesclinic Ab

    Mölndal, Sweden

  • KINGS COLLEGE HOSPITAL - Clinic Trial Unit Academic Department of Rheumatology

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.